Carl Turesson
131 – 140 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Allvarlig lungsjukdom vid RA och TNF-blockering--finns det ett samband?
(
- Contribution to journal › Article
- 2005
-
Mark
Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis
(
- Contribution to journal › Article
-
Mark
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article
-
Mark
Increased stiffness of the abdominal aorta in women with rheumatoid arthritis.
(
- Contribution to journal › Article
- 2004
-
Mark
No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study
(
- Contribution to journal › Article
-
Mark
Septicemia with Staphylococcus aureus, beta-hemolytic streptococei group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra)
(
- Contribution to journal › Letter
-
Mark
Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations?
(
- Contribution to journal › Scientific review
-
Mark
Management of extra-articular disease manifestations in rheumatoid arthritis
(
- Contribution to journal › Scientific review